Monthly Archives: September 2005

Featured Stories

Fracking Should be Kept 600m From Aquifers, Study Says

New research on the safety of hydraulic fracturing (fracking) suggests new wells should not be dug within 600 meters of a water aquifer because underground fractures can extend about that far from a dug well. According to a report from UK’s The Guardian newspaper, researchers and geologists at Durham University have ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa. Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because of concerns regarding the risk of stroke, serious bleeding ...

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Influenza Pandemic a Brewing Storm

There will definitely be another influenza pandemic and no government can afford to be caught off-guard, according to World Health Organization (WHO) Director-General Dr. Lee Jong-wook. Speaking to ministers of health from throughout the Americas at the Pan American Health … Continue reading

Posted in Legal News |

Congress Calls for Investigation into FDA Chiefís Sudden Resignation

Both sides of Capitol Hill are asking questions about the unexpected departure of FDA Commissioner Dr. Lester Crawford.  Crawford stepped down from the FDA’s top post on September 23rd, just two months after a heated confirmation battle in the Senate.  … Continue reading

Posted in Legal News |

Class-Action by Consumer Groups Alleges Pfizer Engaged in a Misleading Advertising Campaign to Boost Lipitor Sales

In the world of prescription drugs, Lipitor is the king with over $10 billion in annual sales. Some consumer groups, however, believe that the drug’s manufacturer, Pfizer Inc., engaged in deceptive advertising of the cholesterol drug in order to boost … Continue reading

Posted in Legal News |

Guidantís Troubles Continue to Grow

Criminal investigators at the U.S. Food and Drug Administration have joined the agency’s probe into how Guidant Corporation handled problems with its heart devices, according to Thursday’s New York Times. The FDA has been looking more closely at Guidant’s products, … Continue reading

Posted in Defective Products |

ADHD Drug, Straterra, May Cause Suicidal Thoughts

Eli Lilly & Company is warning that its ADHD drug, Straterra, may cause suicidal thoughts in children and adolescents.  In a press release dated today, Lilly reported that its Straterra clinical trials database had identified a small but statistically significant … Continue reading

Posted in Legal News |

Vioxx Plaintiff Takes the Stand in New Jersey Trial

Frederick “Mike” Humeston, a 60-year-old Idaho postal worker who suffered a heart attack while taking Vioxx, is suing Merck, contending that the drug maker hid Vioxx’s risks in an effort to preserve sales.  He took the stand Wednesday in the … Continue reading

Posted in Legal News |

Refrigerators and Upright Freezers Recalled Due to Shock Hazard

The U.S. Consumer Product Safety Commission announced the recall of approximately 112,000 Automatic Defrost Upright Freezers and Refrigerators manufactured by WC Wood Company between September 2002 and February 2004.  These units were sold at home improvement and appliance stores between … Continue reading

Posted in Defective Products |

AstraZeneca Reports TOPROL-XL Medication Errors

Users of the beta blocker TOPROL-XL, taken for the treatment of conditions such as hypertension and angina pectoris, need to insure that they are receiving the correct medicine from their doctors and pharmacists.  The Food and Drug Administration (FDA), along … Continue reading

Posted in Health Concerns |

Paxil May Cause Birth Defects

GlaxoSmithKline (GSK) and the Food and Drug Administration (FDA) notified physicians yesterday that PAXIL and PAXIL CR (paroxetine HCI) may be linked to a higher rate of birth defects than currently found with similar drugs. GSK recently conducted a retrospective … Continue reading

Posted in Legal News |

Panic Disorder Increases the Risk of Heart Disease

According to a study in the current issue of Psychosomatic Medicine, people with panic disorder are at double the normal risk for coronary heart disease.  If an individual is also diagnosed with depression, the risk triples. Published in the current … Continue reading

Posted in Health Concerns |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.